dl-VSVG-LacZ, a Vesicular Stomatitis Virus Glycoprotein Epitope-Incorporated Adenovirus, Exhibits Marked Enhancement in Gene Transduction Efficiency

Human Gene Therapy

Volumn 14, Issue 17, 2003, Pages 1643-1652

  Yun, Chae O K ^a   Cho, Eun A ^a   Song, Jae Jin ^a   Kang, Dae Bong ^a   Kim, Eunhee ^a   Sohn, Joo Hyuk ^b   Kim, Joo Hang ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENVELOPE PROTEIN; EPITOPE; PHOSPHATIDYLSERINE; RECOMBINANT PROTEIN; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

ADENOVIRUS; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; COXSACKIE VIRUS; DRUG EFFECT; FEMALE; GENE DELIVERY SYSTEM; GENE FUNCTION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VIVO STUDY; MAMMAL CELL; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS VIRUS; WILD TYPE;

ADENOVIRIDAE; ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CELL SEPARATION; DIMERIZATION; EPITOPES; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GENOTYPE; GLYCOPROTEINS; HUMANS; LAC OPERON; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; VESICULAR STOMATITIS-INDIANA VIRUS;

ADENOVIRIDAE; COXSACKIEVIRUS; MAMMALIA; VESICULAR STOMATITIS VIRUS;

EID: 0344874116     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403322542284     Document Type: Article

References (16)

1. ARAI, T., MATSUMOTO, K., SAITOH, K., UI, M., ITO, T., MURAKAMI, M., KANEGAE, Y., SAITO, I., COSSET, F.L., TAKEUCHI, Y., and IBA, H. (1998). A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines. J. Virol. 72, 1115-1121.
2. BLACKWELL, J.L., MILLER, C.R., DOUGLAS, J.T., LI, H., REYNOLDS, P.N., CARROLL, W.R., PETERS, G.E., STRONG, T.V., and CURIEL, D.T. (1999). Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 125, 856-863.
3. DIRKS, C., and MILLER, A.D. (2001). Many nonmammalian cells exhibit postentry blocks to transduction by gammaretroviruses pseudotyped with various viral envelopes, including vesicular stomatitis virus G glycoprotein. J. Virol. 75, 6375-6383.
4. GU, D.L., GONZALEZ, A.M., PRINTZ, M.A., DOUKAS, J., YING, W., D'ANDREA, M., HOGANSON, D.K., CURIEL, D.T., DOUGLAS, J.T., SOSNOWSKI, B.A., BAIRD, A., AUKERMAN, S.L., and PIERCE, G.F. (1999). Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: Evidence for reduced toxicity and enhanced antitumor activity in mice. Cancer Res. 59, 2608-2614.
5. HAISMA, H.J., PINEDO, H.M., RIJSWIJK, A., DER MEULENMUILEMAN, I., SOSNOWSKI, B.A., YING, W., BEUSECHEM, V.W., TILLMAN, B.W., GERRITSEN, W.R., and CURIEL, D.T. (1999). Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM. Gene Ther. 6, 1469-1474.
6. HALL, M.P., BURSON, K.K., and HUESTIS, W.H. (1998). Interactions of a vesicular stomatitis virus G protein fragment with phosphatidylserine: NMR and fluorescence studies. Biochim. Biophys. Acta 1415, 101-113.
7. HEMMI, S., GEERTSEN, R., MEZZACASA, A., PETER, I., and DUMMER, R. (1998). The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum. Gene Ther. 9, 2363-2373.
8. HIDAKA, C., MILANO, E., LEOPOLD, P.L., BERGELSON, J.M., HACKETT, N.R., FINBERG, R.W., WICKHAM, T.J., KOVESDI, I., ROELVINK, P., and CRYSTAL, R.G. (1999). CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J. Clin. Invest. 103, 579-587.
9. KIM, J., CHO, J.Y., KIM, J.H., JUNG, K.C., and YUN, C.O. (2002). Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy. Cancer Gene Ther. 9, 725-736.
10. LEE, H., SONG, J.J., KIM, E., YUN, C.O., CHOI, J., LEE, B., KIM, J., CHANG, J.W., and KIM, J.H. (2001). Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor. Gene Ther. 8, 268-273.
11. LI, Y., PONG, R.C., BERGELSON, J.M., HALL, M.C., SAGALOWSKY, A.I., TSENG, C.P., WANG, Z., and HSIEH, J.T. (1999). Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy. Cancer Res. 59, 325-330.
12. LIU, M.L., WINTHER, B.L., and KAY, M.A. (1996). Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: Comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J. Virol. 70, 2497-2502.
13. MILLER, C.R., BUCHSBAUM, D.J., REYNOLDS, P.N., DOUGLAS, J.T., GILLESPIE, G.Y., MAYO, M.S., RABEN, D., and CURIEL, D.T. (1998). Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res. 58, 5738-5748.
14. REYNOLDS, P.N., ZINN, K.R., GAVRILYUK, V.D., BALYASNIKOVA, I.V., ROGERS, B.E., BUCHSBAUM, D.J., WANG, M.H., MILETICH, D.J., GRIZZLE, W.E., DOUGLAS, J.T., DANILOV, S.M., and CURIEL, D.T. (2000). A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Mol. Ther. 2, 562-578.
15. SCHLEGEL, R., TRALKA, T.S., WILLINGHAM, M.C., and PASTAN, I. (1983). Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site? Cell 32, 639-646.
16. WHITT, M.A., ZAGOURAS, P., CRISE, B., and ROSE, J.K. (1990). A fusion-defective mutant of the vesicular stomatitis virus glycoprotein. J. Virol. 64, 4907-4913.